Thomas McDonald, MD
Gastroenterology · Sayre, PANPI 1609848696
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $54 of the $65 with a category attached, or 82.1%. Linvatec Corporation accounts for 82.1% of it on its own, with 1 other manufacturer making up the rest. That places this record below the midpoint for gastroenterology clinicians in PA, where the typical reported total is $1,806.
Across 2 payments — averaging $32.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Linvatec Corporation$54
- Johnson & Johnson$12
Across 14 payments — averaging $2361.29 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Gilead$17K
- Bausch Health US, LLC$14K
- Eli Lilly$2K
What the payments were for
- Food & beverage$5482%
- Education$1218%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Linvatec Corporation | 1 | $54 |
| Johnson & Johnson | 1 | $12 |
How this compares
$65 in reported general payments places this provider in the 5th percentile of 935 gastroenterology providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| CreonLipase/Protease/Amylase | 16 | $19,663 |
| LinzessLinaclotide | 13 | $6,725 |
| Sucralfate | 116 | $3,825 |
| Omeprazole | 296 | $2,923 |
| Mesalamine | 11 | $2,639 |
| Lansoprazole | 20 | $1,626 |
| Ursodiol | 11 | $1,575 |
| Pantoprazole Sodium | 127 | $1,361 |
| Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl | 58 | $940 |
| Peg-3350 And ElectrolytesPeg3350/Sod Sulf,bicarb,cl/Kcl | 46 | $692 |
| Esomeprazole Magnesium | 16 | $519 |
| Famotidine | 13 | $378 |
| Lorazepam | 11 | $114 |
Paid to pharmacies, not to this prescriber.
Other gastroenterology in Sayre
- Miguel RegueiroPittsburgh$1.5M
- Adam PeytonAllentown$985K
- Shahin RahimianWaynesboro$592K
- Sandra El-HachemPittsburgh$472K
- Harshit KharaDanville$438K
- Kofi ClarkeHershey$426K
- Michael KochmanPhiladelphia$361K
- Gary LichtensteinPhiladelphia$342K
- Elie AounPittsburgh$323K
- Andrew TinsleyHershey$322K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.